Orforglipron (6 mg × 90 Capsules) from West Lab Chemical is a high-purity, non-peptide GLP-1 receptor agonist designed for advanced metabolic and obesity-related research studies.
Each capsule contains 6 mg of Orforglipron, delivering a total of 540 mg per bottle. This research compound is being studied for its ability to modulate glucose metabolism, reduce appetite, and support insulin sensitivity — offering unique advantages over traditional peptide-based GLP-1 analogs.
For laboratory research use only – not for human consumption.
Packaging: 90 Capsules per bottle
Strength: 6 mg per capsule
Total Content: 540 mg
What is Orforglipron?
Orforglipron, also known as LY3502970, is a first-in-class oral, non-peptide GLP-1 receptor agonist developed for research exploring glucose homeostasis, weight management, and type 2 diabetes pathways.
Unlike peptide-based GLP-1 agonists that require injection, Orforglipron offers oral bioavailability, making it an important molecule for studies focused on gut-brain signaling, energy balance, and metabolic disorders.
In pre-clinical studies, Orforglipron demonstrated potent GLP-1R activation, leading to enhanced insulin secretion, appetite regulation, and improved glucose tolerance — without significantly increasing hypoglycemia risk.
Key Features
-
💊 6 mg of Orforglipron per capsule (540 mg total per bottle)
-
⚗️ Non-peptide GLP-1 receptor agonist – oral bioavailability for diverse models
-
🧪 ≥ 98% purity (HPLC and MS verified)
-
🔬 Ideal for metabolic, obesity, and diabetes research
-
📦 GMP-compliant encapsulated format for precision dosing and stability
Potential Research Applications
(For scientific and educational use only – not for medical claims)
-
Obesity Research: Evaluation of body weight and appetite regulation via GLP-1 signaling.
-
Diabetes and Glucose Studies: Effects on insulin secretion and glucose tolerance.
-
Metabolic Function Models: Exploration of lipid oxidation, insulin resistance, and hepatic metabolism.
-
Gut-Brain Axis Research: Investigating satiety, reward pathways, and energy intake.
-
Pharmacokinetic Analysis: Oral bioavailability and receptor selectivity studies.
Specifications
| Property | Details |
|---|---|
| Compound Name | Orforglipron (LY3502970) |
| Molecular Formula | C41H47N7O6S |
| Molecular Weight | 765.93 g/mol |
| Purity | ≥ 98% (HPLC Verified) |
| Capsule Strength | 6 mg |
| Capsules per Bottle | 90 |
| Total Content | 540 mg |
| Form | Encapsulated Research Compound |
| Grade | Analytical / Research Grade |
| CAS Number | 2255864-69-7 |
Storage Instructions
-
Store at 2 °C – 8 °C (refrigerated).
-
Keep away from direct sunlight and moisture.
-
Seal tightly after use to maintain stability.
-
Handle under sterile lab conditions with PPE.
Why Buy Orforglipron from West Lab Chemical
West Lab Chemical is a trusted supplier of research-grade metabolic and peptide analog compounds, providing premium materials to universities, R&D institutes, and biotechnology laboratories.
Our advantages include:
-
✅ ≥ 98% verified purity with full COA
-
✅ GMP-equivalent manufacturing and packaging
-
✅ Secure international delivery
-
✅ Scientific support for researchers
-
✅ Bulk and institutional discounts available
Every batch of Orforglipron is tested for identity, potency, and purity to meet analytical-grade standards.
Purity & Quality Assurance
All Orforglipron products undergo:
-
HPLC testing for purity verification
-
NMR spectral confirmation
-
Mass spectrometry validation
-
Microbial & heavy metal screening
Purity: ≥ 98%
Solvent Residue: < 0.1%
Heavy Metals: < 10 ppm
Legal Disclaimer
This product is for laboratory research use only.
Not intended for human consumption, medical, or veterinary purposes.
Researchers are responsible for compliance with institutional and regulatory guidelines.
West Lab Chemical accepts no liability for misuse or off-label application.

Reviews
Clear filtersThere are no reviews yet.